HIV Citation List: January 6 - January 19, 2012

Pubmed citations

1. Identification of Molecular Determinants from Moloney Leukemia Virus 10 Homolog (MOV10) Protein for Virion Packaging and anti-HIV-1 Activity. Abudu, A., X. Wang, Y. Dang, T. Zhou, S.H. Xiang, and Y.H. Zheng, Journal of Biological Chemistry, 2012. 287(2): p. 1220-1228; PMID[22105071].

[PubMed].HIV_0106-011912.

2. A Glycomimetic Compound Inhibits DC-SIGN-mediated HIV Infection in Cellular and Cervical Explant Models.. Berzi, A., J.J. Reina, R. Ottria, I. Sutkeviciute, P. Antonazzo, M. Sanchez-Navarro, E. Chabrol, M. Biasin, D. Trabattoni, I. Cetin, J. Rojo, F. Fieschi, A. Bernardi, and M. Clerici, AIDS, 2012. 26(2): p. 127-137; PMID[22045343].

[PubMed].HIV_0106-011912.

3. Recent Progress in Small Molecule CCR5 Antagonists as Potential HIV-1 Entry Inhibitors. Chen, W., P. Zhan, E. De Clercq, and X. Liu, Current Pharmaceutical Design, 2012. [Epub ahead of print]; PMID[22236118].

[PubMed].HIV_0106-011912.

4. The Viral Protein Tat Can Inhibit the Establishment of HIV-1 Latency. Donahue, D.A., B.D. Kuhl, R.D. Sloan, and M.A. Wainberg, Journal of Virology, 2012. [Epub ahead of print]; PMID[22238306].

[PubMed].HIV_0106-011912.

5. Microwave-assisted Synthesis of Small Molecules Targeting the Infectious Diseases Tuberculosis, HIV/AIDS, Malaria and Hepatitis C. Gising, J., L.R. Odell, and M. Larhed, Organic & Biomolecular Chemistry, 2012. [Epub ahead of print]; PMID[22227602].

[PubMed].HIV_0106-011912.

6. Identification of Novel HIV-1 Integrase Inhibitors Using Shape-based Screening, QSAR and Docking Approach. Gupta, P., P. Garg, and N. Roy, Chemical Biology and Drug Design, 2012. [Epub ahead of print]; PMID[22233531].

[PubMed].HIV_0106-011912.

7. Development of a Combination Microbicide Gel Formulation Containing IQP-0528 and Tenofovir for the Prevention of HIV Infection. Ham, A.S., S.R. Ugaonkar, L. Shi, K.W. Buckheit, H. Lakougna, U. Nagaraja, G. Gwozdz, L. Goldman, P.F. Kiser, and R.W. Buckheit, Jr., Journal of Pharmaceutical Sciences, 2012. [Epub ahead of print]; PMID[22227864].

[PubMed].HIV_0106-011912.

8. Effect of Efavirenz on UDP-glucuronosyltransferase 1A1, 1A4, 1A6, and 1A9 Activities in Human Liver Microsomes. Ji, H.Y., H. Lee, S.R. Lim, J.H. Kim, and H.S. Lee, Molecules, 2012. 17: p. 851-860; PMID[22252501].

[PubMed].HIV_0106-011912.

9. Cyclophillin a (CyPA) Is Required for Efficient HCMV DNA Replication and Reactivation. Keyes, L.R., M.G. Bego, M. Soland, and S. St Jeor, Journal of General Virology, 2012.[Epub ahead of print]; PMID[22238232].

[PubMed].HIV_0106-011912.

10. Computational Modeling Methods for QSAR Studies on HIV-1 Integrase Inhibitors (2005-2010). Ko, G.M., A.S. Reddy, R. Garg, S. Kumar, and A.R. Hadaegh, Current Computer-Aided Drug Design, 2012 [Epub ahead of print]; PMID[22242796].

[PubMed].HIV_0106-011912.

11. Influence of the Nucleobase and Anchimeric Assistance of the Carboxyl Acid Groups in the Hydrolysis of Amino Acid Nucleoside Phosphoramidates. Maiti, M., S. Michielssens, N. Dyubankova, E. Lescrinier, A. Ceulemans, and P. Herdewijn, Chemistry, 2012. 18(3): p. 857-868; PMID[22173724].

[PubMed].HIV_0106-011912.

12. HIV-1 Envelope-Dependent Restriction of CXCR4-Using Viruses in Children but Not Adult Untransformed CD4+ T Lymphocyte Lines. Mariani, S.A., I. Brigida, A. Kajaste-Rudnitski, S. Ghezzi, A. Rocchi, A. Plebani, E. Vicenzi, A. Aiuti, and G. Poli, Blood, 2012.[Epub ahead of print]; PMID[22234680].

[PubMed].HIV_0106-011912.

13. Interaction of I50V Mutant and I50L/A71V Double Mutant HIV-Protease with Inhibitor TMC114 (Darunavir): Molecular Dynamics Simulation and Binding Free Energy Studies. Meher, B.R. and Y. Wang, Journal of Physical Chemistry B, 2012. [Epub ahead of print]; PMID[22239286].

[PubMed].HIV_0106-011912.

14. Novel HIV-1 Fusion Inhibition Peptides: Designing the Next Generation of Drugs. Miyamoto, F. and E.N. Kodama, Antiviral Chemistry and Chemotherapy, 2012. 22(4): p. 151-158; PMID[22182762].

[PubMed].HIV_0106-011912.

15. Altered Strand Transfer Activity of a Multiple-drug-resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant with a Dipeptide Fingers Domain Insertion. Nguyen, L.A., W. Daddacha, S. Rigby, R.A. Bambara, and B. Kim, Journal of Molecular Biology, 2012. 415(2): p. 248-262; PMID[22100453].

[PubMed].HIV_0106-011912.

16. A Synthetic C34 Trimer of HIV-1 gp41 Shows Significant Increase in Inhibition Potency. Nomura, W., C. Hashimoto, A. Ohya, K. Miyauchi, E. Urano, T. Tanaka, T. Narumi, T. Nakahara, J.A. Komano, N. Yamamoto, and H. Tamamura, ChemMedChem, 2012. [Epub ahead of print]; PMID[22247043].

[PubMed].HIV_0106-011912.

17. Cleavage of Pyrene-Stabilized RNA Bulge Loops by trans-(+/-)-Cyclohexane-1,2-diamine. Patel, S., J. Rana, J. Roy, and H. Huang, Chemistry Central Journal, 2012. 6(1): p. 3; PMID[22244351].

[PubMed].HIV_0106-011912.

18. Critical Differences in HIV-1 and HIV-2 Protease Specificity for Clinical Inhibitors. Tie, Y., Y.F. Wang, P.I. Boross, T.Y. Chiu, A.K. Ghosh, J. Tozser, J.M. Louis, R.W. Harrison, and I.T. Weber, Protein Science, 2012. [Epub ahead of print]; PMID[22238126].

[PubMed].HIV_0106-011912.

19. Pegylated poly(ethylene imine) Copolymer-delivered siRNA Inhibits HIV Replication in Vitro. Weber, N.D., O.M. Merkel, T. Kissel, and M.A. Munoz-Fernandez, Journal of Controlled Release, 2012. 157(1): p. 55-63; PMID[21930169].

[PubMed].HIV_0106-011912.

20. Broad Antiviral Activity and Crystal Structure of HIV-1 Fusion Inhibitor Sifuvirtide. Yao, X., H. Chong, C. Zhang, S. Waltersperger, M. Wang, S. Cui, and Y. He, Journal of Biological Chemistry, 2012. [Epub ahead of print]; PMID[22228771].

[PubMed].HIV_0106-011912.

21. Nitrogen-containing Polyhydroxylated Aromatics as HIV-1 Integrase Inhibitors: Synthesis, Structure-Activity Relationship Analysis, and Biological Activity. Yu, S., L. Zhang, S. Yan, P. Wang, T. Sanchez, F. Christ, Z. Debyser, N. Neamati, and G. Zhao, Journal of Enzyme Inhibition and Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22233539].

[PubMed].HIV_0106-011912.

ISI Web of Knowledge citations

22. Synthesis of New Derivatives of Inositol-containing Phospholipid Dimer Analogs as Potential Inhibitors of Virus Adsorption. Baranova, E.O., T.P.L. Dang, S.V. Eremin, D.S. Esipov, N.S. Shastina, and V.I. Shvets, Pharmaceutical Chemistry Journal, 2011. 45(6): p. 344-350; ISI[000298114300005].

[WOS]. HIV_0106-011912.

23. The R-Diastereomer of 6 '-o-Toluoyl-carba-LNA Modification in the Core Region of siRNA Leads to 24-Times Improved RNA Silencing Potency against the HIV-1 compared to its S-counterpart. Dutta, S., N. Bhaduri, R.S. Upadhayaya, N. Rastogi, S.G. Chandel, J.K. Vandavasi, O. Plashkevych, R.A. Kardile, and J. Chattopadhyaya, MedChemComm, 2011. 2(11): p. 1110-1119; ISI[000297960100013].

[WOS]. HIV_0106-011912.

24.Discovery of gs-8374, a Potent Human Immunodeficiency Virus Type 1 Protease Inhibitor with a Superior Resistance Profile. He, G.X., Z.-Y. Yang, M. Williams, C. Callebaut, T. Cihlar, B.P. Murray, C. Yang, M.L. Mitchell, H. Liu, J. Wang, M. Arimilli, E. Eisenberg, K.M. Stray, L.K. Tsai, M. Hatada, X. Chen, J.M. Chen, Y. Wang, M.S. Lee, R.G. Strickley, Q. Iwata, X. Zheng, C.U. Kim, S. Swaminathan, M.C. Desai, W.A. Lee, and L. Xu, MedChemComm, 2011. 2(11): p. 1093-1098; ISI[000297960100010].

[WOS]. HIV_0106-011912.

25.Synthesis, Structure-Activity Relationships, and Mechanism of Action of anti-HIV-1 Lamellarin Alpha 20-sulfate Analogues. Kamiyama, H., Y. Kubo, H. Sato, N. Yamamoto, T. Fukuda, F. Ishibashi, and M. Iwao, Bioorganic and Medicinal Chemistry, 2011. 19(24): p. 7541-7550; ISI[000297860100026].

[WOS]. HIV_0106-011912.

26.A Specific Protein Disorder Catalyzer of HIV-1 Nef. Lugari, A., S. Breuer, T. Coursindel, S. Opi, A. Restouin, X. Shi, A. Nazabal, B.E. Torbett, J. Martinez, Y. Collette, I. Parrot, S.T. Arold, and X. Morelli, Bioorganic and Medicinal Chemistry, 2011. 19(24): p. 7401-7406; ISI[000297860100010].

[WOS]. HIV_0106-011912.